Clinical Trial Update: Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus [NA]

View source ↗

Summary

This clinical trial update reports that a pilot study evaluating oral 852A for elimination of high-grade dysplasia in Barrett's Esophagus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus

Drugs mentioned

• Oral 852A

Snippet

Sponsor: Rogers, B.H. Gerald, M.D. | Conditions: Barrett Esophagus | NA | Status: TERMINATED